Wang S - Search Results

1

Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn's disease: results from the EVOLVE study.

Mantzaris GJ, Bressler B, Adsul S, Luo M, Colby C, Brett NR, Saha S, Kamble P, Wang S, Yarur A. Mantzaris GJ, et al. Among authors: wang s. Eur J Gastroenterol Hepatol. 2024 Mar 1;36(3):281-291. doi: 10.1097/MEG.0000000000002690. Epub 2023 Dec 27. Eur J Gastroenterol Hepatol. 2024. PMID: 38179874 Free PMC article.

2

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review.

Patel D, Martin S, Luo M, Ursos L, Lirio RA, Kamble P, Wang S. Patel D, et al. Among authors: wang s. Crohns Colitis 360. 2022 Jul 8;4(3):otac020. doi: 10.1093/crocol/otac020. eCollection 2022 Jul. Crohns Colitis 360. 2022. PMID: 36777427 Free PMC article.

3

Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn's Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study.

Yarur A, Mantzaris GJ, Wang S, Adsul S, Kamble P, Cook E, Sajeev G, Guerin A, Bressler B. Yarur A, et al. Among authors: wang s. Adv Ther. 2024 Jun;41(6):2324-2341. doi: 10.1007/s12325-024-02825-w. Epub 2024 Apr 24. Adv Ther. 2024. PMID: 38658485 Free PMC article.

4

Using supervised machine learning approach to predict treatment outcomes of vedolizumab in ulcerative colitis patients.

Chen J, Girard M, Wang S, Kisfalvi K, Lirio R. Chen J, et al. Among authors: wang s. J Biopharm Stat. 2022 Mar;32(2):330-345. doi: 10.1080/10543406.2021.2009500. Epub 2021 Dec 9. J Biopharm Stat. 2022. PMID: 34882518 Free article.

5

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis.

Cappell K, Taylor A, Johnson BH, Gelwicks S, Wang S, Gerber M, Leffler DA. Cappell K, et al. Among authors: wang s. Am J Gastroenterol. 2020 Nov;115(11):1821-1829. doi: 10.14309/ajg.0000000000000759. Am J Gastroenterol. 2020. PMID: 33156101 Free PMC article.

6

Response to letter to editor.

Chen J, Kisfalvi K, Girard M, Wang S, Lirio R. Chen J, et al. Among authors: wang s. J Biopharm Stat. 2022 Sep 3;32(5):805-806. doi: 10.1080/10543406.2022.2065503. Epub 2022 May 23. J Biopharm Stat. 2022. PMID: 35605090 No abstract available.

7

Preoperative intravenous versus oral iron supplementation for elective surgery: evidence based on 12 randomized trials.

Yue L, Zhang J, Li C, Wang Z, Qi L, Zhao Y, Wang S, Shang M, Li C, Sun H. Yue L, et al. Among authors: wang s. Postgrad Med. 2025 Jan 16. doi: 10.1080/00325481.2025.2454218. Online ahead of print. Postgrad Med. 2025. PMID: 39817823 Review.

8

Discovery of a heparan sulfate binding domain in monkeypox virus H3 as an anti-poxviral drug target combining AI and MD simulations.

Zheng B, Duan M, Huang Y, Wang S, Qiu J, Lu Z, Liu L, Tang G, Cheng L, Zheng P. Zheng B, et al. Among authors: wang s. Elife. 2025 Jan 16;13:RP100545. doi: 10.7554/eLife.100545. Elife. 2025. PMID: 39817728

9

A case of surgical treatment combined with interventional therapy for refractory hemodialysis access with catheter-related right atrial thrombosis.

Wang SF, Xu ZJ, Cui TL. Wang SF, et al. J Vasc Access. 2025 Jan 16:11297298241313005. doi: 10.1177/11297298241313005. Online ahead of print. J Vasc Access. 2025. PMID: 39817462

10

Sakuranetin Prevents Acetaminophen-Induced Liver Injury via Nrf2-Induced Inhibition of Hepatocyte Ferroptosis.

Long Z, Yu X, Li S, Cheng N, Huo C, Zhang X, Wang S. Long Z, et al. Among authors: wang s. Drug Des Devel Ther. 2025 Jan 10;19:159-171. doi: 10.2147/DDDT.S497817. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39816848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119,106 results

Search Page

Filters